You are here

BCRF Grantee Since


Area(s) of Focus

Arti Hurria, MD

Director, Cancer and Aging Research Program
Associate Professor of Medical Oncology
Member, Cancer Control and Population Sciences Program
City of Hope Comprehensive Cancer Center
Duarte, California

Current Research

Cognitive decline is one of the most feared consequences of aging among older adults and even minor changes can seriously impact quality of life and the ability to live independently. Dr. Hurria’s team is working to address these concerns in a study of older, long-term (5-15 years) survivors of breast cancer. The study evaluates the differences in memory between breast cancer survivors who received chemotherapy vs. those who did not compared to healthy women of the same age who  never had cancer. The study is designed to determine how changes in cognitive function in cancer survivors compare to women with no history of cancer and to identify biomarkers of cognitive decline that can be measured in the blood. The ultimate goal of this this work is to develop a model which can predict the trajectory of changes in cognitive function in cancer survivors and  guide the development of interventions to preserve the cognition and well-being of older survivors of breast cancer.


Dr. Arti Hurria is a geriatrician and oncologist, focusing on care of the older patient with breast cancer. She completed a geriatric fellowship in the Harvard Geriatric Fellowship Program, followed by a hematology-oncology fellowship at Memorial Sloan Kettering Cancer Center. Dr. Hurria is the Director of the Cancer and Aging Research Program at City of Hope. She is a recipient of the Paul Beeson Career Development Award in Aging Research and the American Society of Clinical Oncology-Association of Specialty Professors-Junior Development Award in Geriatric Oncology. Dr. Hurria is Vice Chair of the Alliance Cancer in the Elderly Committee, Chair of the National Comprehensive Cancer Network Senior Adult Oncology Panel, President for the International Society of Geriatric Oncology, and Editor-in Chief of the Journal of Geriatric Oncology. In addition, Dr. Hurria is PI on a U13 grant in collaboration with the NIA and NCI to identify and develop research methodology that will lead evidence-based recommendations to improve clinical care for older adults with cancer. She also serves as national PI on an R01 funded grant evaluating clinical and biological predictors of chemotherapy toxicity in older adults with breast cancer. These grants are executed in collaboration with members from the Cancer and Aging Research Group, which Dr. Hurria founded and leads. Additionally, Dr. Hurria is multi-PI on a R01 funded study evaluating the cognitive function of long-term survivors of breast cancer and PI on a U13 grant which will focus on incorporating aging research across specialties and providing a forum to support the expanded pool of physician-scientists focused in aging research. In 2013, she received the ASCO B.J. Kennedy Award for Scientific Excellence in Geriatric Oncology.